Blockade of IL-22 by using its neutralizing antibody reversed the therapeutic effect of 6-formylindolo (3, 2-b) carbazole on the trinitrobenzenesulfonic acid-induced colitis in mice. This evidence concerns the gene IL22 and colitis.